Study of prescription pattern and adverse drug reactions of antineoplastic drugs in patients with breast cancer in a tertiary care teaching hospital

Journal Title: Indian Journal of Pharmacy and Pharmacology - Year 2017, Vol 4, Issue 4

Abstract

Introduction: To study current prescription pattern of drugs and adverse drug reactions (ADRs) in patients of carcinoma breast. Methodology: This observational, cross-sectional study was carried out in Radiotherapy department of a tertiary care teaching hospital for a period of two months. Patients diagnosed with breast carcinoma and attending Radiotherapy department for chemotherapy were included. Prescriptions were analysed and details of drugs prescribed were recorded. Patients were enquired about occurrence of any ADRs and details were recorded. Preventability and severity of ADRs were assessed by modified Schumock and Thornton scale and modified Hartwig and Siegel scale respectively. Results: A total of 70 patients were included in the study. Cyclophosphamide was the most commonly used chemotherapeutic agent (77.14%), followed by Doxorubicin (68.57%) and 5-FU (44.29%). Most commonly prescribed regimen was Cyclophosphamide + 5FU + Doxorubicin followed by Cyclophosphamide + Doxorubicin. Nausea was the most commonly reported ADR followed by alopecia, vomiting and blackening of nails. Maximum ADRs were reported with Cyclophosphamide + Doxorubicin + 5 FU combination followed by Cyclophosphamide + Doxorubicin combination. Out of the total ADRs 60.11% belonged to the category of “definitely preventable” while 74.15% of ADRs were of less severity categorized as “mild level 1” severity. Conclusion: Cyclophosphamide was the most commonly prescribed drug. Highest incidence of ADRs was observed with Cyclophosphamide + Doxorubicin + 5 FU. Inspite of prophylactic antiemetic treatment majority of patients had nausea and vomiting which indicates that more vigorous measures to prevent emesis need to be undertaken since these ADRs of antineoplastic drugs are usually preventable.

Authors and Affiliations

Renuka L. Kadam, Vijay M. Motghare, Smita Sontakke, A. K. Diwan

Keywords

Related Articles

Precedence of Cognizant Adverse Drug Reactions (ADRs) Reporting in a South Indian Tertiary Care Hospital: A Prospective Study

Objectives: The present study was conducted with the objectives to analyze the ADRs reported to the ADR Monitoring Centre at a tertiary care hospital in Dakshina Kannada district, South India. Methods: Adverse drug react...

Use of Proton Pump Inhibitors – A drug utilization study

Background: In 2006 PPI was the third most frequently prescribed drug in Australia. In United States, UK and New Zealand similar trends were observed. Utilization of proton pump inhibitors is increasing continuously. Dif...

Hypolipidemic activity of Lannea coromandelica Houtt. leaves in Triton X-100 induced hyperlipidemic rats

Lannea coromandelicaHoutt have multiple pharmacological activities including antiinflammatory aphrodisiac hypotensive anti microbial ulcerative stomatitis wound healing leprosy gout elephantiasis and cholera Therefore th...

A case report on succinylcholine hypersensitivity presenting as severe bronchospasm

Succinylcholine is a depolarizing neuromuscular blocking agent useful as an adjunct to general anaesthesia Hypersensitivity to succinylcholine might lead to flushing skin rash bronchospasm and shock However incidence of...

Prescription pattern of anti-epileptic medications in a tertiary care centre

Introduction The objective of this study was to study the prescribing pattern of antiepileptic medications in patients with epilepsy in a tertiary care hospitalMaterials and Methods This was an observational study conduc...

Download PDF file
  • EP ID EP295983
  • DOI 10.18231/2393-9087.2017.0045
  • Views 77
  • Downloads 0

How To Cite

Renuka L. Kadam, Vijay M. Motghare, Smita Sontakke, A. K. Diwan (2017). Study of prescription pattern and adverse drug reactions of antineoplastic drugs in patients with breast cancer in a tertiary care teaching hospital. Indian Journal of Pharmacy and Pharmacology, 4(4), 210-214. https://europub.co.uk/articles/-A-295983